COVID-19

Date: April 29, 2020 COVID – 19 Update

Dear Patients,

As we continue to navigate through these evolving and challenging times, we want to give you an update on where we stand. We continue to be committed to providing excellent orthopedic service and care to our patients.

Effective today, all of the surgical facilities where we practice, including surgery centers and hospitals, will be allowing elective cases effective May 4th. OrthoNorCal is now scheduling all types of elective surgeries.  Please rest assured that the surgery centers and hospitals are proactively taking comprehensive measures to assure the safety of patients and staff in response to the COVID-19 epidemic.

Additionally, our clinics continue to be open our regular hours for orthopedic care. We have the capability to perform X-ray, MRI, and fracture care at our clinics. This may alleviate your worries about seeking urgent orthopedic care and can lessen the current burden on the local Emergency Rooms.

Like our surgical facility partners, OrthoNorCal is taking multiple steps to protect our patients from COVID-19. We are following CDC guidelines and following Social Distancing precautions.  A few examples of this are:

1) We are limiting seating space in our waiting rooms to make sure that patients have at least 6 feet of space.

2) If patients wish to check-in and then wait in their car for their appointment, we will accommodate them.

3) We have telephone follow-up appointments with some patients who have routine follow up examinations.  If they want to be seen, we will be available to them.

We will update you with changes in this rapidly evolving situation. We know that this is an uncertain and anxious time.   We want to reassure you that we will be here for your orthopedic needs. We remain firm in our goal to give your patients outstanding, safe, compassionate care.

Yours Truly,

The Team at OrthoNorCal

Dr. Kornelis Poelstra: The future of robotic spine surgery

Kornelis Poelstra, MD, PhD, recently implanted what was reported to be the first Molybdenum-Rhenium rod in a patient during a spinal fusion on the West Coast.

Dr. Poelstra, of The Robotic Spine Institute of Silicon Valley in Los Gatos, Calif., used the Mazor X robot to plan the operation and position the hardware.

Here, he breaks down the procedure with the MoRe alloy and discusses how robotics will develop in the long-term as the industry looks for more cost-effective solutions to spine surgery.

Note: Responses are lightly edited for style and clarity.

Question: How do you see the MoRe alloy developing in spine? Will the new range of smaller implants enable more cost-effective options for spine surgery?

Dr. Kornelis Poelstra: The MoRe alloy is comprised of unique material properties and is 2-3 times stronger than currently used titanium- or cobalt-chromium alloys. It has four times greater durability and almost no recoil when bending the material. Because of its strength, it is capable of creating two-rod constructs with greater durability than prior four-rod constructs made of cobalt chromium or titanium, which decreases the cost of the entire construct.

The material is pure so there are no trace elements of nickel or other contaminants required to keep it stable, which reduces the risk for harmful ion release, decreases metal wear as well as potential adverse and allergic reactions by the patient. Imagine the possibilities for ortho-trauma, upper extremity, foot and ankle and joint replacement surgeries.

The entire construct can be created with 50 percent less metal by volume, which decreases the bioburden for the patient, hopefully diminishing the likelihood for postoperative unexplained back pain and pseudoarthrosis formation.

Q: Can you break down the preoperative planning and intraoperative procedures with the Mazor X robot? Is there anything you did differently using the MoRe alloy?

KP: With the Mazor X robot, the actual technology platform is more important than the robotic arm. Utilizing highly advanced planning capabilities for hardware placement and deformity correction, we can now dial in our correction with much greater comfort prior to surgery, and then execute it flawlessly following our own, well-defined plan in 3D space, which reduces stress on the team during surgery and the cognitive burden to the surgeon.

Where we are traditionally quite stressed performing osteotomies and complex deformity corrections, having a carefully planned procedure to follow makes surgery much less time-consuming and makes it much better to execute the individual tasks required for a successful operation.

Based on the small size of the MoRe hardware, screw placement can be more refined preoperatively, with greater soft tissue sparing approaches to the spine through smaller incisions and less soft tissue disruption to get the construct created. Altogether, this has led to fewer complications and readmissions, and reduced the length of hospital stays for patients.

Q: What does the future look like for robotics in spine? What further applications could be on the horizon for robotic spine surgery? 

KP: The future for robotics is bright. In addition to trajectory guidance to place hardware and perform complex preoperative planning procedures, robots are soon going to be able to have greater autonomy in the OR, I hope. We must discuss these advances together with regulatory bodies such as the FDA, but this autonomy will not be far off.

Robotic systems should be able to nearly autonomously place hardware, further reducing outliers and human error, help us with discectomy procedures and end plate preparation in a more predictable form as well as with decompression surgery or the spinal canal. Utilizing advanced learning, I am confident that we can start manipulating muscle and fascia and have robotic assistance soon that will help us open and close surgical approaches.

People should also not forget the highly advanced predictive analytics that help us with the decision-making processes of which surgical technique to offer to which patient. Robotic and computer systems are much more capable of analyzing large amounts of variables to help us reduce complications and make better choices for our patient population.

Q: How will robotics fit in as the industry looks for more value-based care and cost-effective options in spine surgery? 

KP: Cost effectiveness does not come out of one individual encounter or a single procedure for one patient. I think greater cost effectiveness will come about as we treat large groups of patients more appropriately with better technology and reduce their 90-day readmission and complication rates, get them back sooner to gainful employment and allow them to become independent and take care of their families.

In the intermediate to long-term follow-up, better index surgery should reduce adjacent segment degeneration, pseudoarthroses or failed fusions and hardware failure, which can potentially lead to a reduction in post-laminectomy type back pain, reduced narcotic use and the provision of a greater quality of life for the population as a whole.

Joint and Spine Community Seminar

Joint and Spine Community Seminar

OrthoNorCal surgeon Dr. Abidi is speaking on Thursday, February 20 from 5:30pm to 7:30pm at Dominican Hospital Education Center, Room B2 1555 Soquel Drive, Santa Cruz, CA. To register for this free seminar please call Crystal Olson at (831) 457-7070.

Most people wait too long for knee replacement surgery, study says

(CNN)Living with knee pain? A new study has found that 90% of Americans with osteoarthritis suffer too long before having a knee replacement that could improve their quality of life.

“When people wait too long, they lose more and more function and can’t exercise or be active, thus leaving them open to weight gain, depression and other health problems,” said lead investigator Hassan Ghomrawi, associate professor of surgery at Northwestern University’s Feinberg School of Medicine.
In addition, the surgery may not be as successful, Ghomrawi said.
“There are multiple studies that have shown that patients who do surgery when their function is very deteriorated may improve quite a bit, but their improvement is still not to the average,” Ghomrawi said. “They lag behind in optimal benefit.”
On the flip side, the study also found that 25% of people who do choose knee surgery are getting it too early, running significant risks, including potential complications, while incurring the cost of major surgery potentially without getting much extra benefit in mobility.
“There are a million knee surgery procedures occurring in the United States each year,” Ghomrawi said, “and 25% of those are premature. That’s a lot of patients.”
Because artificial knees wear out after 20 years or so, early adopters are also setting themselves up for yet another knee replacement later in life, Ghomrawi said, which is typically a much more difficult surgery with a poorer outcome than the original.

An objective algorithm

The study, published Monday in the Journal of Bone and Joint Surgery, followed over 8,000 people with symptoms of knee osteoarthritis for up to eight years.
While other studies have looked at people who underwent the knife, this study is believed to be the first to examine the timeliness of knee replacement among people who might benefit from the procedure, Ghomrawi said.
The study applied an objective measure to determine the “ideal timing” of knee replacement. It used an algorithm first developed in Europe in 2003, then updated in 2014 by Virginia Commonwealth researchers who analyzed data from a smaller study of 200 people and found a third had surgery too early.
“There are 16 unique combinations that can be assigned based on age, knee stability, and whether the patient has slight, moderate, intense or severe pain,” Ghomrawi said.
Knee stability is defined as the not only the ability to bend, but also how “wiggly” the knee is due to loose tendons, and also takes into account clicking and grinding sounds.
In addition, the measurement looks at the severity of the osteoarthritis on X-rays — “if it’s bone on bone” — as well as how many parts of the knee are affected: the femur (thigh bone), tibia (shin bone), and patella (kneecap).
After factoring all of these elements, Ghomrawi and his team assigned patients in the study to three categories: timely — they had the surgery within two years of the replacement becoming potentially appropriate; delayed — no surgery or surgery that waited until after those two years; and premature.

The cost of premature surgery

This isn’t the first study to try and apply an objective criteria to what has been a traditionally subjective conversation between a patient and doctor. The UK’s National Health Service commissioned a study last year to see if they could apply objective measures to the decision.
The effort is partly driven by cost — In the UK the cost can range from 11,000 pounds ($14,300) to 15,000 pounds ($19,467) and, according to a 2015 study, if there are complications or the surgery must be redone, it can rise to 75,000 pounds ($97,313).
In the United States, according to a study by Blue Cross Blue Shield, a typical knee replacement surgery can range between $12,000 to $70,000 depending on what part of the country you live in.
And then there’s the growing popularity of the surgery: The American Academy of Orthopedic Surgeons projects knee replacements in the US alone will grow by up to 189% in the next decade, for a projected 1.28 million procedures by 2030.
The US population of baby boomers is aging, as are their knees, but those numbers may be partially driven by the rise in knee replacements among those under the age of 65. A 2012 study found total knee replacement more than tripled for people aged 45 to 64 between 1999 and 2008; for those over 65, it only doubled. The cost for all those operations, the study found, was more than $9 billion.

Can an objective algorithm work?

Not everyone believes that such an objective approach will succeed in the health care environment.
“I would say this paper looks at the issue from the perspective of the experts and not necessarily from a patient perspective,” said Dr. Bart Ferket, an assistant professor of population health science and policy at the Icahn School of Medicine at Mount Sinai Hospital in New York City.
“It’s an attempt to objectify things that are subjective,” said Mount Sinai orthopedic surgeon Dr. Edward Adler, who, like Ferket, was not involved in the study.
Pain, for example, is subjective and could interfere with the algorithm’s ability to assess knee stability and a patient’s reported levels of pain.
“Some people will allow you to move their knee even though their knee hurts a lot,” Adler said. “They can have a lot of pain, you wouldn’t know it. They function well.
“There are other people who have a little bit of pain and everybody around them has to know about it,” he added. “So it’s fairly subjective as to how much you tolerate before you get your knee replaced.”
Ghomrawi agrees there could be excellent subjective reasons why a person might decide to get an early knee transplant instead of deciding to wait.
One scenario, he says, for a transplant at a younger age, for example, could stem from financial considerations. A candidate for the surgery may elect to go through with it, thinking, “I’m the only financial support for my family; I’m maintaining my functional level so that I can continue to be the breadwinner for my family.”
Or perhaps an older person has a very painful knee, “but they’re bearing with it because they’re taking care of their spouse,” Ghomrawi said.
Still, studies show many people aren’t happy with the outcome of their knee replacement; a 2010 study found almost 20% said they were dissatisfied.
Objective or subjective, Adler said there needs to be a realistic assessment by each person of what a new knee can really accomplish. If a person has the surgery before the onset of severe or significant pain, the patient may not see enough improvement.
“Knee replacements are not really made for tennis and running,” he said, “They are made for walking long distances and performing activities of daily living.
“What God gave you is not necessarily the same as what I can give you,” Adler said.”if your goal is to be normal, that’s a difficult thing to obtain when your knee is coming out of a box.”

Northern California Spine Surgeon Dr. Kornelis Poelstra Leads Spinal Breakthrough with Implantation of First Molybdenum Rhenium Fusion on West Coast

Preeminent Northern California Spine Surgeon Dr. Kornelis Poelstra, of The Robotic Spine Institute of Silicon Valley, has this week announced the latest medical breakthrough for the spine world, with the first-ever procedure on the West Coast using a Molybdenum-Rhenium rod in a patient.

The newly FDA cleared MiRus Europa™ Pedicle Screw System is the smallest pedicle screw system in the world for lumbar fusion, and incorporates MoRe®, a new class of implant material. A proprietary superalloy, MoRe® (Molybdenum-Rhenium) is the first novel alloy to be FDA cleared in decades.

This patented superalloy has greater strength and scratch and fatigue resistance compared to titanium, cobalt and iron alloys. MoRe® also has a superior biocompatibility profile with better hydrophilicity and osteoconductivity along with decreased ion release and biofilm formation compared to traditional alloys.

Due to its much greater strength and fatigue resistance, MoRe® implants are significantly smaller and allow patients to have smaller incisions and less soft tissue disruption.

Always focused on the next generation of spine care, the world renowned Orthopedic and Neurological Spine Surgeon used his co-developed Mazor navigated robotic platform during the posterior fusion procedure, allowing him to pre-plan his implantation of this new device in the patient.

As one of the main developers of the Mazor, offered by Medtronic, use of this platform often leads to increased efficiency, advanced precision, and rapidly reduces time spent under anesthesia in the operating room.

With a PhD in Biomedical Engineering from the University of Groningen in The Netherlands, Dr. Poelstra is on the frontline of the design and development of spinal robotics that assist in spinal fusions. Formerly based in Destin, Florida, Dr. Poelstra has performed nearly 1,000 complex robotic cases, more than any other spine surgeon in the world.

The Robotic Spine Institute of Silicon Valley, based in Los Gatos, California, is led by Dr. Poelstra, and has developed an outstanding reputation for delivering superior care to patients and for being at the forefront of pioneering many advancements in the spinal care field. The Institute prides itself on its team of the best spine surgeons and innovators in the world, and its strategic partnerships with the medical industry’s leading specialists and professionals.

MiRus is a medical device company that has developed and is commercializing proprietary novel biomaterials, implants and software solutions for spine, orthopaedics and cardiovascular disease. We are addressing the demands of today’s healthcare environment with an integrated platform of pre-operative planning and risk assessment tools, a breakthrough navigation and robotics system and post-operative monitoring and risk mitigation. Find more information about MiRus at http://www.mirusmed.com.

For more information on Dr. Poelstra and his The Robotic Spine Institute of Silicon Valley, visit http://www.robo-spine.com.

Augmedics Announces FDA 510K Clearance and U.S. Launch of xvision™, the First Augmented Reality Guidance System for Surgery

The xvision consists of a transparent near-eye-display headset and all elements of a traditional navigation system. It accurately determines the position of surgical tools, in real time, and a virtual trajectory is then superimposed on the patient’s CT data. The 3D navigation data is then projected onto the surgeon’s retina using the headset, allowing him or her to simultaneously look at the patient and see the navigation data without averting his or her eyes to a remote screen during the procedure. The system is designed to revolutionize how surgery is done by giving the surgeon better control and visualization, which may lead to easier, faster and safer surgeries.

Augmedics successfully completed a percutaneous laboratory study with the xvision Spine at Rush University Medical Center with investigators Frank Phillips, M.D., Camilo Molina, M.D., Kornelis Poelstra, M.D., Ph.D., Larry Khoo, M.D., and Matthew Colman, M.D. Ninety-three screws were positioned in the thoracic and sacro-lumbar areas of five different cadavers. The study was conducted as evidence to the FDA to evaluate the accuracy of the xvision Spine system by comparing the actual screw tip position and trajectory versus the virtual. The result of overall clinical accuracy, analyzed by two independent neuro-radiologists, was 98.9 percent using the Heary (thoracic) and Gertzbein (lumbar) scales. This study adds to the evidence of accuracy and usability found last year in another cadaver study performed by two surgeons from Johns Hopkins Medicine, Daniel Sciubba, M.D., and Timothy Witham, M.D., one surgeon from Sheba Tel-Hashomer, Israel, Ran Harel, M.D., and one from Assaf Harofeh, Israel, Yigal Mirovsky. The study last year was conducted at Vista Labs, an independent lab in Baltimore, with results published in the Journal of Neurosurgery: Spine.

“The ability that Augmedics’ xvision provides to visualize the patient’s spinal anatomy in 3D, coupled with live CT images as a retina display, is game changing,” said Frank Phillips, M.D., Professor of Orthopaedic Surgery, Rush University Medical Center. “The efficiency and accuracy this augmented reality technology enables in placing spinal implants without looking away from the surgical field – as well as the ability to “see the spine” through the skin in minimally invasive procedures – differentiates the xvision from conventional spinal navigation platforms. The economics of the xvision system are also compelling in both the hospital and the surgicenter environment.”

“Augmedics’ mission is to give surgeons more control by creating technological advances that cater to their needs and fit within their workflow,” said Nissan Elimelech, founder and CEO of Augmedics. “xvision is our first product of many to follow that will revolutionize surgery, as it gives surgeons the information they need, directly within their working field of sight, to instill technological confidence in the surgical workflow and help them do their jobs as effectively and safely as possible.”

xvision is now available for sale in the United States, with headset distribution expected to begin in early 2020. Augmedics plans to explore additional surgical applications for xvision beyond spinal surgery. The system’s small footprint, economical cost and compatibility with current instrumentation is designed to allow easy integration into any surgical facility nationwide.